Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
MeiraGTxmeiragtx.com · Low evidenceMeiraGTx is a clinical stage genetic medicine company developing therapies for both rare and prevalent diseases. It focuses on precision control of gene expression through its riboswitch gene regulation platform and end-to-end manufacturing ecosystem.
Parse Score